Publication | Closed Access

Ganoderma lucidum polysaccharide peptide (GLPP) attenuates rheumatic arthritis in rats through inactivating NF-κB and MAPK signaling pathways

ImmunologyPathologyInnate ImmunityInflammatory ArthritisInflammationRheumatoid DisorderRheumatic ArthritisOsteoarthritisInflammatory Rheumatic DiseaseRheumatoid ArthritisRheumatologyAutoimmune DiseaseRheumatic DiseasesChronic InflammationAutoimmunityImmune FunctionInflammatory DiseaseAnti-inflammatoryMapk Signaling PathwaysMedicine